DK0700399T3 - Derivater i 36-stilling af rifamyciner og anvendelse af sådanne som antimikrobemidler - Google Patents
Derivater i 36-stilling af rifamyciner og anvendelse af sådanne som antimikrobemidlerInfo
- Publication number
- DK0700399T3 DK0700399T3 DK94916937T DK94916937T DK0700399T3 DK 0700399 T3 DK0700399 T3 DK 0700399T3 DK 94916937 T DK94916937 T DK 94916937T DK 94916937 T DK94916937 T DK 94916937T DK 0700399 T3 DK0700399 T3 DK 0700399T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- image
- alkylamino
- sec
- date
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93108337 | 1993-05-24 | ||
| EP93110315 | 1993-06-29 | ||
| PCT/EP1994/001428 WO1994028002A1 (en) | 1993-05-24 | 1994-05-05 | 36-derivatives of rifamycins and their use as antimicrobial agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0700399T3 true DK0700399T3 (da) | 2001-11-26 |
Family
ID=26133222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94916937T DK0700399T3 (da) | 1993-05-24 | 1994-05-05 | Derivater i 36-stilling af rifamyciner og anvendelse af sådanne som antimikrobemidler |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5786350A (da) |
| JP (1) | JP3566962B2 (da) |
| KR (1) | KR100325562B1 (da) |
| AT (1) | ATE206427T1 (da) |
| AU (1) | AU687817B2 (da) |
| CA (1) | CA2160243C (da) |
| DE (1) | DE69428535T2 (da) |
| DK (1) | DK0700399T3 (da) |
| ES (1) | ES2164704T3 (da) |
| IL (1) | IL109691A (da) |
| PT (1) | PT700399E (da) |
| WO (1) | WO1994028002A1 (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
| EP1453837A4 (en) * | 2001-11-21 | 2007-11-07 | Activbiotics Inc | TARGETED THERAPEUTIC AGENTS AND USES THEREOF |
| US7820652B2 (en) * | 2003-09-24 | 2010-10-26 | Activbiotics Pharma, Llc | Regimen for the administration of rifamycin-class antibiotics |
| WO2005070941A1 (en) * | 2004-01-13 | 2005-08-04 | Cumbre Pharmaceuticals Inc. | Rifamycin imino derivatives effective against drug-resistant microbes |
| US7247634B2 (en) * | 2004-01-13 | 2007-07-24 | Cumbre Pharmaceuticals Inc. | Rifamycin derivatives effective against drug-resistant microbes |
| US7256187B2 (en) | 2004-03-10 | 2007-08-14 | Cumbre Pharmaceuticals Inc. | Rifamycin C-11 oxime derivatives effective against drug-resistant microbes |
| US7265107B2 (en) | 2004-03-10 | 2007-09-04 | Cumbre Pharmaceuticals Inc. | Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes |
| US7250413B2 (en) * | 2004-04-26 | 2007-07-31 | Cumbre Pharmaceuticals Inc. | C-25 carbamate rifamycin derivatives with activity against drug-resistant microbes |
| WO2006012470A1 (en) | 2004-07-22 | 2006-02-02 | Cumbre Pharmaceuticals Inc. | Rifamycin derivatives for treating microbial infections |
| SI1889198T1 (sl) | 2005-04-28 | 2015-02-27 | Proteus Digital Health, Inc. | Farma-informacijski sistem |
| MX2009002893A (es) | 2006-09-18 | 2009-07-10 | Raptor Pharmaceutical Inc | Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap). |
| WO2010095940A2 (en) | 2009-02-20 | 2010-08-26 | To-Bbb Holding B.V. | Glutathione-based drug delivery system |
| NZ596876A (en) | 2009-05-06 | 2014-01-31 | Lab Skin Care Inc | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
| WO2014043320A1 (en) * | 2012-09-12 | 2014-03-20 | Salix Pharmaceuticals, Inc. | Methods of administering rifaximin without producing antibiotic resistance |
| SG11202006994XA (en) | 2018-01-24 | 2020-08-28 | Univ Rockefeller | Antibacterial compounds, compositions thereof, and methods using same |
| EP4003200A4 (en) | 2019-07-23 | 2023-08-02 | The Rockefeller University | ANTIBACTERIAL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF |
| WO2024068926A1 (en) | 2022-09-30 | 2024-04-04 | BioVersys AG | Rifabutin analogs for the treatment of disease |
-
1994
- 1994-05-05 DK DK94916937T patent/DK0700399T3/da active
- 1994-05-05 JP JP50015095A patent/JP3566962B2/ja not_active Expired - Lifetime
- 1994-05-05 US US08/792,035 patent/US5786350A/en not_active Expired - Lifetime
- 1994-05-05 PT PT94916937T patent/PT700399E/pt unknown
- 1994-05-05 DE DE69428535T patent/DE69428535T2/de not_active Expired - Lifetime
- 1994-05-05 WO PCT/EP1994/001428 patent/WO1994028002A1/en active IP Right Grant
- 1994-05-05 CA CA002160243A patent/CA2160243C/en not_active Expired - Lifetime
- 1994-05-05 AT AT94916937T patent/ATE206427T1/de active
- 1994-05-05 AU AU68430/94A patent/AU687817B2/en not_active Expired
- 1994-05-05 ES ES94916937T patent/ES2164704T3/es not_active Expired - Lifetime
- 1994-05-05 KR KR1019950705232A patent/KR100325562B1/ko not_active IP Right Cessation
- 1994-05-19 IL IL10969194A patent/IL109691A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT700399E (pt) | 2002-02-28 |
| DE69428535T2 (de) | 2002-08-01 |
| WO1994028002A1 (en) | 1994-12-08 |
| DE69428535D1 (de) | 2001-11-08 |
| AU6843094A (en) | 1994-12-20 |
| JP3566962B2 (ja) | 2004-09-15 |
| CA2160243A1 (en) | 1994-12-08 |
| ATE206427T1 (de) | 2001-10-15 |
| KR100325562B1 (ko) | 2002-07-22 |
| JPH08511249A (ja) | 1996-11-26 |
| IL109691A (en) | 1998-10-30 |
| IL109691A0 (en) | 1994-08-26 |
| AU687817B2 (en) | 1998-03-05 |
| US5786350A (en) | 1998-07-28 |
| CA2160243C (en) | 2007-08-28 |
| KR960702466A (ko) | 1996-04-27 |
| ES2164704T3 (es) | 2002-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0700399T3 (da) | Derivater i 36-stilling af rifamyciner og anvendelse af sådanne som antimikrobemidler | |
| DK0868424T3 (da) | 4-Pyrimidinyl- eller 4-pyrazinyl-piperazinyl-phenyloxazolidinonderivater, fremstilling deraf og anvendelse deraf som antibakterielle midler | |
| AU686222B2 (en) | Cyclodepsipeptide compound | |
| MY139244A (en) | 2,3-dihydro-6-nitroimidazo [2,1-b] oxazole | |
| EG25017A (en) | N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials. | |
| AU4798000A (en) | Triarylimidazoles | |
| BRPI0608690B8 (pt) | uso de uma composição antimicrobiana | |
| ATE296821T1 (de) | Triarylimidazol-derivate als cytokin-inhibitoren | |
| AU3973697A (en) | Isoxazoline derivatives useful as antimicrobials | |
| KR970705392A (ko) | 신규한 항생제 조성물 및 그람-양성 세균 및 마이코플라스마 감염의 치료 방법(novel antibiotic compounds and methods to treat grampositive bacterial and mycoplasmal infections) | |
| AU7001996A (en) | Novel derivatives of cyclodepsipeptide PF1022 substance | |
| GEP20084437B (en) | Novel lincomycin derivatives possessing antimicrobial activity | |
| NO20065889L (no) | 3-`4-{6-substituert alkanoyl)pyridin-3-yf}-3-fenyl!-5-(1 H-1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler. | |
| BR0015177A (pt) | ésteres de ácido benzóico de oxazolidinonas possuindo um substituinte hidroxiacetilpiperazina | |
| HK1048118A1 (en) | Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient | |
| AU4540096A (en) | Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics | |
| WO2004043928A3 (en) | N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents | |
| ATE400179T1 (de) | Verwendung von pyrimidinetrion-derivaten als acetylcholinesterase-hemmer, diese enthaltende zusammensetzungen und deren verwendungen | |
| BR0312550A (pt) | Derivados de nocatiacina o-derivatizados | |
| AU4321597A (en) | Pyridobenzoxazine derivatives | |
| DK0596917T3 (da) | Benzimidazolanthelmintika | |
| BR0108758A (pt) | Ecta antiinfectivo | |
| EP1066831A4 (en) | PROPHYLACTIC / THERAPEUTIC AGENTS AGAINST URINARY DISORDERS | |
| EG20464A (en) | Amidothiophosphate derivative and insecticide nematocide acaricide containing the same as active ingredient | |
| TH27181A (da) |